Mahamaya Lifesciences IPO Financials
The Mahamaya Lifesciences IPO provide an overview of the company's performance over the previous financial periods. Investors can evaluate key financial metrics such as assets, revenue, profit after tax (PAT), net worth, reserves & surplus, and total borrowings to assess the company's financial strength, profitability, and long-term growth potential before investing in the IPO.
As of 30 Jun 2025, Mahamaya Lifesciences Limited reported assets of ₹218.87 crore, revenue of ₹84.04 crore, and a profit after tax (PAT) of ₹4.1 crore. The company had a net worth of ₹53.5 crore and reserves & surplus of ₹35.73 crore, and total borrowings are 57.72 crore.
Revenue increased by 217.91% in 31 Mar 2025 and decreased by 39.05% in 31 Mar 2024 and decreased by 15.62% in 31 Mar 2023, while Profit After Tax (PAT) grew by 215.61% in 31 Mar 2025 and declined by 59.66% in 31 Mar 2024 and declined by 28.16% in 31 Mar 2023, respectively.
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Mahamaya Lifesciences Limited Financials (₹ in Crores)
| Particular | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Revenue | 84.04 | 267.17 | 162.83 | 137.4 |
| Profit After Tax | 4.1 | 12.94 | 5.22 | 3.75 |
| Net Worth | 53.5 | 49.42 | 24.66 | 19.44 |
| Reserve & Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowings | 57.72 | 58.11 | 54.63 | 24.37 |
EPS Pre
7.29%
EPS Post
7.01%
P/E Pre
15.65
P/E (Post Issue)
16.25x
Company Financial Information
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
What is the Revenue of Mahamaya Lifesciences Limited?
Mahamaya Lifesciences Limited reported revenue of ₹84.04 crore as of 30 Jun 2025. Revenue figures from the Mahamaya Lifesciences IPO provide insights into sales growth, market demand, and business scalability.
What is the Profit After Tax (PAT) of Mahamaya Lifesciences Limited?
Mahamaya Lifesciences Limited reported a Profit After Tax (PAT) of ₹4.1 crore as of 30 Jun 2025. PAT represents the company's net profit after deducting all operating expenses, interest, taxes, and other applicable charges, making it a key indicator of overall profitability.
What is the PE Ratio of Mahamaya Lifesciences Limited?
Mahamaya Lifesciences Limited has a Price-to-Earnings (P/E) ratio of 15.65x based on the IPO issue price. The P/E ratio compares the company's share price with its earnings per share (EPS) and is a commonly used valuation metric to assess whether a stock is fairly valued relative to its earnings and industry peers.